60
Liora Life Sciences launches $640.6M raise in Utah health care venture
Company raise · Raising · SANDY, UT · Form D filed 2026-10-01
Liora Life Sciences, a Delaware LLC incorporated in 2025, is raising up to $640.63M under Regulation D 506(c) with general solicitation permitted. The company has sold $300K to 2 investors so far and requires a $50K minimum investment.
Note: Entity incorporated in 2025, filed first Form D in October 2026; first sale occurred September 2026. Mega-sized offering ($640.6M) with minimal capital raised ($300K) and only 2 investors suggests early-stage capital formation.
$50M+ raiseFirst raise on EDGARother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| William Tanenbaum | Manager of Managing Member |
| N/A Liora MGMT, LLC | Managing Member |
Signed by William C. Tanenbaum, Manager of Managing Member.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.